[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-429448-105":59,"doc-detail-429448-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","correction-correction-ldb2-is-a-novel-diagnostic-and-prognostic-biomarker-and-inhibits-bladder-cancer-metastasis-by-activating-p38-mapkerk12jnk-signaling-pathway","Correction - Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway","","A published correction updates the original article’s author affiliation grouping for a study titled “LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.” The notice specifies that the affiliation order in the original version should be changed, listing the revised grouping across multiple departments and hospitals in Beijing and Shijiazhuang. It also reiterates open-access licensing terms and publisher neutrality.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/correction-correction-ldb2-is-a-novel-diagnostic-and-prognostic-biomarker-and-inhibits-bladder-cancer-metastasis-by-activating-p38-mapkerk12jnk-signaling-pathway/429448/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/correction-correction-ldb2-is-a-novel-diagnostic-and-prognostic-biomarker-and-inhibits-bladder-cancer-metastasis-by-activating-p38-mapkerk12jnk-signaling-pathway/429448.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the correction change in the original article?","Question",{"text":112,"@type":113},"It corrects the author affiliation groupings, which were presented incorrectly in the original version.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What biological signaling pathway is referenced in the corrected article title?",{"text":117,"@type":113},"The pathway is p38 MAPK/ERK1/2/JNK signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"Under what license is the article published?",{"text":121,"@type":113},"The article is published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},429448,1790792886,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":8,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":81,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Clinical and Experimental Medicine (2026) 26:62  \n[https://doi.org/10.1007/s10238-025-02009-y](https://doi.org/10.1007/s10238-025-02009-y)  \nCORRECTION  \nCorrection: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/ JNK signaling pathway  \nYue Li1,3 · Bin Zhao3 · Wenzhi Gao2 · Yucai Wu1 · TaiTian1,3 · Shimeng Zhao3,4 · Jilong Zhang1 · Ran Li1,3 · Shiming He1 · Yanqing Gong1 · Jianguo Ma3 · Xuesong Li1  \n© The Author(s) 2025  \nCorrection to: Clinical and Experimental Medicine  \n(2025) 26:9  \n[https://doi.org/10.1007/s10238-025-01854-1](https://doi.org/10.1007/s10238-025-01854-1)  \nIn the original version of the article, the affiliation group which previously read as  \nYue Li 1, Bin Zhao 1, Wenzhi Gao2, Yucai Wu3, Tai Tian 1,3, Shimeng Zhao 1,4, Jilong Zhang3, Ran Li 1,3, Shiming He3, Yanqing Gong3, Jianguo Ma 1, Xuesong Li3  \n1Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang 050000, China 2Department of Urology, Peking University First Hospital – Miyun Hospital, Beijing 100034, China  \n3Department of Urology, Peking University First Hospital, Beijing 100034, China  \n4Department of Urology, Hebei Childrens Hospital, Shijiazhuang 050000, China  \nThe original article can be found online at [https://doi.org/10.1007/s10](https://doi.org/10.1007/s10)[ ](https://doi.org/10.1007/s10)238-025-01854-1.  \n􀀍 Jianguo Ma[mjg1971@aliyun.com](mjg1971@aliyun.com)  \n􀀍 Xuesong Li [pineneedle@sina.com](pineneedle@sina.com)  \n1 Department of Urology, Peking University First Hospital, Beijing 100034, China  \n2 Department of Urology, Peking University First Hospital – Miyun Hospital, Beijing 100034, China  \n3 Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang 050000, China  \n4 Department of Urology, Hebei Children’s Hospital, Shijiazhuang 050000, China  \nBut should have been  \nYue Li 1,3, Bin Zhao3, Wenzhi Gao2, Yucai Wu 1, Tai Tian 1,3, Shimeng Zhao3,4, Jilong Zhang 1, Ran Li 1,3, Shiming He 1, Yanqing Gong 1, Jianguo Ma3, Xuesong Li 1  \n1Department of Urology, Peking University First Hospital, Beijing 100034, China  \n2Department of Urology, Peking University First Hospital – Miyun Hospital, Beijing 100034, China  \n3Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang 050000, China 4Department of Urology, Hebei Children’s Hospital, Shijiazhuang 050000, China  \nOpen Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/) .  \nPublisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.  \n1 3","cbCaiiJBRSNrjZG6","https://ap.wps.com/l/cbCaiiJBRSNrjZG6","pdf",494928,"English","# Correction\n## Updated author affiliation grouping\n## Open access license and publisher note","[{\"question\":\"What does the correction change in the original article?\",\"answer\":\"It corrects the author affiliation groupings, which were presented incorrectly in the original version.\"},{\"question\":\"What biological signaling pathway is referenced in the corrected article title?\",\"answer\":\"The pathway is p38 MAPK/ERK1/2/JNK signaling.\"},{\"question\":\"Under what license is the article published?\",\"answer\":\"The article is published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).\"}]","Correction - Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway | PDF",1790650114]